![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Spectranetics Wins CE Mark for Smaller Stellarex DCB
Spectranetics Wins CE Mark for Smaller Stellarex DCB
![](https://www.fdanews.com/ext/resources/test/Device_Images2/Spectranetics-Logo.gif?t=1479862829&width=430)
Spectranetics has received CE Marking for its Stellarex 0.014 drug-coated angioplasty balloon (DCB).
The device is designed to treat small vessels, below-the-knee disease and critical limb ischemia in patients.
Stellarex is not available in the U.S. — Cynthia Jessup
Upcoming Events
-
21Oct